A novel coronavirus outbreak of global health concern, Lancet, vol.395, p.31986257, 2020. ,
,
A Novel Coronavirus from Patients with Pneumonia in China, N Engl J Med, vol.382, issue.8, p.7092803, 2019. ,
A new coronavirus associated with human respiratory disease in China, Nature, vol.579, issue.7798, p.7094943, 2020. ,
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan, Emerg Microbes Infect, vol.9, issue.1, p.7067204, 2020. ,
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing, Nature, vol.583, p.32353859, 2020. ,
Stimulation of Innate Immunity by Host and Viral RNAs, Trends Immunol, vol.40, issue.12, pp.1134-1182, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02383514
Interferon-Stimulated Genes: What Do They All Do?, Annu Rev Virol, vol.6, issue.1, pp.567-84, 2019. ,
Nuclear RNF2 inhibits interferon function by promoting K33-linked STAT1 disassociation from DNA, Nat Immunol, vol.19, issue.1, pp.41-52, 2018. ,
Murine Coronavirus Cell Type Dependent Interaction with the Type I Interferon Response, Viruses, vol.1, issue.3, pp.689-712, 2009. ,
Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125, Proc Natl Acad Sci, vol.104, issue.18, p.1863485, 2007. ,
PKR: A Kinase to Remember, Front Mol Neurosci, vol.11, p.6333748, 2019. ,
Protein synthesis inhibition and GADD34 control IFN-beta heterogeneous expression in response to dsRNA, EMBO J, vol.36, issue.6, p.5350567, 2017. ,
Integration of PKR-dependent translation inhibition with innate immunity is required for a coordinated anti-viral response, FEBS Lett, vol.589, issue.14, p.6, 2015. ,
Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses, PLoS Pathog, vol.12, issue.10, p.5081173, 2016. ,
Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication, J Virol, vol.92, issue.20, p.6158436, 2018. ,
Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells, Nat Commun, vol.9, issue.1, p.3317, 2018. ,
Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance, PLoS Pathog, vol.14, issue.11, p.6287881, 2018. ,
Single-cell analysis shows that paracrine signaling by first responder cells shapes the interferon-beta response to viral infection, Sci Signal, vol.8, issue.363, p.16, 2015. ,
Antiviral interferon response at single-cell resolution, Immunol Rev, vol.285, issue.1, pp.72-80, 2018. ,
Multi-layered stochasticity and paracrine signal propagation shape the type-I interferon response, Mol Syst Biol, vol.8, p.3377992, 2012. ,
Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses, mBio, vol.5, issue.3, pp.1174-1188, 2014. ,
, , p.4030454
A systems immunology approach to plasmacytoid dendritic cell function in cytopathic virus infections, PLoS Pathog, vol.6, issue.7, 2010. ,
,
SARS and MERS: recent insights into emerging coronaviruses, Nat Rev Microbiol, vol.14, issue.8, pp.523-557, 2016. ,
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study, Lancet, vol.361, issue.9371, pp.13412-13417, 2003. ,
Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis, BMJ, vol.326, issue.7403, pp.1358-62, 2003. ,
,
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice, Cell Host Microbe, vol.19, issue.2, p.4752723, 2016. ,
Pathogenesis of severe acute respiratory syndrome, Curr Opin Immunol, vol.17, issue.4, pp.404-414, 2005. ,
Lung pathology of fatal severe acute respiratory syndrome, Lancet, vol.361, issue.9371, pp.13413-13420, 2003. ,
How the SARS coronavirus causes disease: host or organism?, J Pathol, vol.208, issue.2, pp.142-51, 2005. ,
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes, J Clin Invest, vol.130, pp.3625-3664, 2019. ,
, , p.6715373
Plasmacytoid Dendritic Cells: Development, Regulation, and Function, Immunity, vol.50, issue.1, p.6342491, 2019. ,
Cell-Cell Sensing of Viral Infection by Plasmacytoid Dendritic Cells, J Virol, vol.90, issue.22, p.5105643, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01909011
Plasmacytoid dendritic cells control T-cell response to chronic viral infection, Proc Natl Acad Sci, vol.109, issue.8, pp.3012-3019, 2012. ,
Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual, Immunity, vol.33, issue.6, p.3588567, 2010. ,
Sensing of immature particles produced by dengue virus infected cells induces an antiviral response by plasmacytoid dendritic cells, PLoS Pathog, vol.10, issue.10, p.4207819, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01078023
PACSIN1 regulates the TLR7/9-mediated type I interferon response in plasmacytoid dendritic cells, Eur J Immunol, vol.42, issue.3, p.3656478, 2012. ,
AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells, Proc Natl Acad Sci U S A, vol.107, issue.46, pp.19973-19981, 2010. ,
Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science, vol.329, pp.1530-1534, 2010. ,
, , p.3063333
Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses, Elife, vol.7, p.6008049, 2018. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01822838
Plasmacytoid Dendritic Cells and Infected Cells Form an Interferogenic Synapse Required for Antiviral Responses, Cell Host Microbe, vol.25, issue.5, pp.730-775, 2019. ,
Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon, Blood, vol.109, issue.3, pp.1131-1138, 2007. ,
Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection, J Virol, vol.84, issue.3, p.2812346, 2009. ,
Treatment of SARS with human interferons, Lancet, vol.362, issue.9380, p.7112413, 2003. ,
Interferon-beta 1a and SARS coronavirus replication, Emerg Infect Dis, vol.10, issue.2, p.3322919, 2004. ,
Severe acute respiratory syndromerelated coronavirus is inhibited by interferon-alpha, J Infect Dis, vol.189, issue.7, p.7109643, 2004. ,
Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin, Sci Rep, vol.3, p.3629412, 2013. ,
MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment, J Gen Virol, vol.94, p.3749523, 2013. ,
SARS-CoV-2 is sensitive to type I interferon pretreatment ,
Antiviral activities of type I interferons to SARS-CoV-2 infection, Antiviral Res, vol.179, p.104811, 2020. ,
An Infectious cDNA Clone of SARS-CoV-2, Cell Host Microbe, vol.27, issue.5, p.7153529, 2020. ,
Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset, J Infect Dis, vol.212, issue.12, p.7107395, 2015. ,
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun, vol.11, p.31924756, 2020. ,
, , p.6954302
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients, Emerg Microbes Infect, vol.9, issue.1, p.7170362, 2020. ,
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients, Cell Host Microbe, vol.27, issue.6, p.7196896, 2020. ,
SARS-CoV-2 productively infects human gut enterocytes, p.7199907 ,
Deconvolution of pro-and antiviral genomic responses in Zika virus-infected and bystander macrophages, Proc Natl Acad Sci U S A, vol.115, issue.39, p.6166801, 2018. ,
The defective component of viral populations, Curr Opin Virol, vol.33, pp.74-80, 2018. ,
IFITM-Family Proteins: The Cell's First Line of Antiviral Defense, Annu Rev Virol, vol.1, pp.261-83, 2014. ,
IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms, Viruses, vol.6, issue.9, p.4189045, 2014. ,
Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus, PLoS Pathog, vol.7, issue.1, p.3017121, 2011. ,
Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study, BMC Infect Dis, vol.6, p.1550407, 2006. ,
URL : https://hal.archives-ouvertes.fr/inserm-00089620
Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection, mBio, vol.10, issue.2, p.6437052, 2019. ,
The Zinc Finger Antiviral Protein restricts SARS-CoV-2. bioRxiv 134379 ,
Novel host restriction factors implicated in HIV-1 replication, J Gen Virol, vol.99, issue.4, pp.435-481, 2018. ,
A diverse range of gene products are effectors of the type I interferon antiviral response, Nature, vol.472, issue.7344, p.3409588, 2011. ,
Inhibition of HIV-1 particle assembly by 2',3'-cyclic-nucleotide 3'-phosphodiesterase, Cell Host Microbe, vol.12, issue.4, p.3498451, 2012. ,
Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity, Nature, vol.505, issue.7485, p.4077721, 2014. ,
LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step, Nat Commun, vol.9, issue.1, p.30190477, 2018. ,
, , p.6127192
LY6E impairs coronavirus fusion and confers immune control of viral disease, p.2020 ,
,
Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors, Cell Host Microbe, vol.14, issue.2, pp.136-183, 2013. ,
, , p.3779433
Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells, EMBO J, vol.36, issue.12, p.5470047, 2017. ,
The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry, Cell Host Microbe, vol.12, issue.4, pp.544-57, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01110072
Interferon induction of IFITM proteins promotes infection by human coronavirus OC43, Proc Natl Acad Sci, vol.111, issue.18, p.4020042, 2014. ,
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, vol.181, issue.2, p.7102627, 2020. ,
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues, Cell, vol.181, issue.5, p.7252096, 2020. ,
Increasing Host Cellular Receptor-Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV Infection, p.963348 ,
Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines, Biochem Biophys Res Commun, vol.326, issue.4, pp.905-913, 2005. ,
, , p.7092851
Increased sensitivity of SARScoronavirus to a combination of human type I and type II interferons, Antivir Ther, vol.9, issue.6, pp.1003-1014, 2004. ,
Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study, Clin Infect Dis, vol.70, issue.9, pp.1837-1881, 2020. ,
Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study, Lancet Infect Dis, vol.14, issue.11, p.7106357, 2014. ,
SARS: systematic review of treatment effects, PLoS Med, vol.3, issue.9, p.1564166, 2006. ,
Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study, JAMA, vol.290, issue.24, pp.3222-3230, 2003. ,
IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study, J Antimicrob Chemother, vol.70, issue.7, pp.2129-2161, 2015. ,
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques, Nat Med, vol.10, issue.3, p.7095986, 2004. ,
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study, Int J Infect Dis, vol.20, p.7110882, 2014. ,
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial, Lancet, vol.395, issue.20, pp.31042-31046, 2020. ,
Fundamentals of aerosol therapy in critical care, Crit Care, vol.20, issue.1, p.269, 2016. ,
, , p.5054555
The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update, Transl Respir Med, vol.2, 2014. ,
,
Interferon-?2b Treatment for COVID-19, Frontiers in Immunology, vol.11, issue.11, p.1061, 2020. ,
COVID-19: lambda interferon against viral load and hyperinflammation, EMBO Mol Med, vol.12, issue.6, p.12465, 2020. ,
, , p.7267110
Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19, Clin Infect Dis, p.453, 2020. ,
, , p.7184357
COVID-19 and emerging viral infections: The case for interferon lambda, J Exp Med, vol.217, issue.5, p.7155807, 2020. ,
Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion, J Exp Med, vol.217, issue.1, p.7037241, 2020. ,
Interferon-lambda Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness, Immunity, vol.46, issue.5, pp.875-90, 2017. ,
Interferon-lambdas: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract, Front Immunol, vol.8, p.1232, 2017. ,
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections, J Virol, vol.84, issue.11, p.2876583, 2010. ,
Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells, p.59667 ,
Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science. 2020: eabc3545 ,
Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction, J Exp Med, vol.206, issue.7, pp.1603-1617, 2009. ,
Epstein-Barr virusencoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro, J Gen Virol, vol.89, pp.2833-2875, 2008. ,
Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement, Nat Commun, vol.8, p.5309800, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02075366
Mozobil(R) (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration, Antivir Chem Chemother, vol.27, p.6379795, 2019. ,
TRIM8 is required for virusinduced IFN response in human plasmacytoid dendritic cells, Sci Adv, vol.5, issue.11, p.6867881, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02404478
Development of Pin1 inhibitors and their potential as therapeutic agents, Curr Med Chem, vol.27, issue.20, pp.3314-3329, 2020. ,
Disease-promoting effects of type I interferons in viral, bacterial, and coinfections, J Interferon Cytokine Res, vol.35, issue.4, p.4389918, 2015. ,
A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection, Proc Natl Acad Sci U S A, vol.106, issue.5, pp.1560-1565, 2009. ,
Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection, Cell, vol.146, issue.6, p.3176439, 2011. ,
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals, Cell, vol.181, issue.7, pp.1489-1501, 2020. ,
, , p.7237901